ISALXIX — International Symposium on Acute Leukemias XIX (ISALXIX) - Biology and Treatment Strategies

The symposium is taking place again in Munich, Germany, in-person from Sunday, March 16 until Wednesday, March 19, 2025. Additionally to the XI Main Sessions two free contributions sessions MS V (Poster session) and MS IX (Best of Free Contributions Session) will additionally deliver the possibility to all those who want to present their own research data in form of a free contribution and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias. We therefore encourage all who are interested in actively participating in ISALXIX with a free contribution to submit their abstract(s). All accepted abstracts will be part of the open access ISALXIX supplement published in ANNALS OF HEMATOLOGY and in the Poster Viewing and Discussion Session (MSV). Abstract Submission Deadline: October 31, 2024.

Topics: MS I: Biology of Acute Leukemias MS II: Biology in Acute Leukemias MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis MS IV: Novel Approaches and Targeted Therapies in AML MS VI: Risk adapted Therapy of AML MS VII: Biology and Treatment of APL MS VIII: MRD in Acute Leukemias: Methods and Clinical Applications MS X: Immunotherapy for Acute Leukemias MS XI: ALL: Biology and Treatment Strategies